Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBreedon Regulatory News (BREE)

Share Price Information for Breedon (BREE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 367.50
Bid: 367.00
Ask: 367.50
Change: 4.00 (1.10%)
Spread: 0.50 (0.136%)
Open: 371.00
High: 371.00
Low: 363.00
Prev. Close: 363.50
BREE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Results of Reverse Accelerated Bookbuild

10 Mar 2023 07:00

RNS Number : 5112S
Deutsche Bank AG, Frankfurt
10 March 2023
 

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH SUCH PUBLICATION OR DISTRIBUTION IS UNLAWFUL. THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND THE INFORMATION CONTAINED HEREIN DOES NOT CONSTITUTE OR FORM PART OF AN OFFER TO BUY, SELL, ISSUE, ACQUIRE OR SUBSCRIBE FOR, OR THE SOLICITATION OF AN OFFER TO BUY, SELL, ISSUE, ACQUIRE OR SUBSCRIBE FOR, ANY SECURITIES IN THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR IN ANY OTHER JURISDICTION.

 

FOR IMMEDIATE RELEASE

 

10 March 2023

 

 Results of Reverse Accelerated Bookbuild

 

Following the announcement on 09 March 2023, Abicad Holding Limited ("Abicad") is pleased to confirm the results of the reverse accelerated bookbuild (the "RABB"), pursuant to which it will acquire approximately 5.3 million ordinary shares of Breedon Group plc ("Breedon") at a price of 75 pence per share. The RABB is expected to settle on 14 March 2023.

 

As a result of this transaction, Abicad will hold approximately 170.3 million ordinary shares of Breedon. Its current board representative is Amit Bhatia, who is the Non-executive Chairman of Breedon.

 

Abicad is a long-term investor in Breedon and intends to hold its shares (including the additional shares acquired pursuant to the RABB) for investment purposes. Abicad has been a supportive shareholder of Breedon since the transformational acquisition of Hope Construction Materials in 2016. The purchase of additional shares in this transaction is a signal of Abicad's continued belief in the business and Breedon's overall strategic direction.

 

Deutsche Bank Aktiengesellschaft ("Deutsche Bank") is acting as Sole Bookrunner for the RABB on behalf of Abicad.

 

 

 

 

 

For further information contact:

 

Deutsche Bank Aktiengesellschaft

 

(Sole Bookrunner)

Stephane Gruffat

Mark Hankinson

Simon Hollingsworth

Parag Manudhane

 

 

Tel: +44 (0) 207 545 8000

 

 

IMPORTANT NOTICES

 

This announcement and the information contained herein is not for release, publication or distribution, directly or indirectly, in whole or in part, in or into the United States, Australia, Canada or Japan or any other jurisdiction in which such publication or distribution is unlawful. This announcement is for information purposes only and the information contained herein does not constitute or form part of an offer to buy, sell, issue, acquire or subscribe for, or the solicitation of an offer to buy, sell, issue, acquire or subscribe for, any securities in the United States, Australia, Canada, Japan or in any other jurisdiction, nor shall there be any offer, solicitation, sale or purchase of securities in any jurisdiction in which such offer, solicitation, sale or purchase would be unlawful. Any failure to comply with these restrictions may constitute a violation of the securities laws of such jurisdictions.

 

This announcement is not an offer of securities for sale into the United States. The securities of Breedon have not or will not be registered under the U.S. Securities Act of 1933, as amended, and may not be offered or sold in the United States, except pursuant to an applicable exemption from registration.

 

The distribution of this announcement may be restricted by law in certain jurisdictions and persons into whose possession any document or other information referred to herein comes should inform themselves about and observe any such restriction.

 

The RABB is not being directed, directly or indirectly, to Breedon investors located in the United States of America, or to agents, nominees, trustees, custodians or other persons acting for the account or benefit of such U.S. shareholders, or in any other jurisdiction where to do so would be unlawful.

 

This announcement is only directed at (and is only being distributed to persons outside the United States who are) (i) persons in any member state of the European Economic Area who are qualified investors ("Qualified Investors") within the meaning of Article 2 of the Prospectus Regulation (Regulation (EU) 2017/1129 of 14 June 2017) (and amendments thereto to the extent implemented in the relevant member state); or (ii) persons in the United Kingdom who are both (A) investment professionals within the meaning of Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the "Order"); or (B) high net worth companies, or persons to whom it can otherwise be lawfully distributed, falling within the meaning of Article 49(2)(a) to (d) of the Order; and (C) qualified investors as defined in Article 2 of the UK Prospectus Regulation (Regulation (EU) 2017/1129 of 14 June 2017 as it has effect in the domestic law of the United Kingdom by virtue of the European Union (Withdrawal) Act 2018) (such persons referred to in this sub-paragraph (ii) being "relevant persons"). This release must not be acted on or relied on (a) in the United Kingdom, by persons who are not relevant persons, or (b) in any member state of the European Economic Area, by persons who are not Qualified Investors, or (c) elsewhere, by persons who are not permitted to sell or dispose of securities in the RABB pursuant to applicable legislation.

 

Any investment or investment activity referred to in this announcement is only available to, and will only be engaged in with, (1) relevant persons, in the United Kingdom; (2) Qualified Investors, in any member state of the European Economic Area; and (3) persons elsewhere who are permitted to sell or dispose of securities in the RABB pursuant to applicable legislation. Deutsche Bank reserves the absolute right to determine who may participate in the RABB.

 

Participating in the RABB shall constitute an irrevocable offer by such participant to sell to Abicad the total number of shares accepted for purchase from that participant by Deutsche Bank on behalf of Abicad. Investors offering shares for purchase in the RABB will be deemed to represent, warrant and undertake to Deutsche Bank and Abicad that: (a) the investor is the legal and beneficial owner and has full power and authority to sell, assign or transfer the shares being sold in the RABB (together with all rights attaching thereto) and, when the same are purchased by Abicad, Abicad will acquire such shares free and clear of all liens, charges, restrictions, claims, equitable interests, encumbrances, pre-emption rights and third party rights and together with all rights attaching thereto and such representation and warranty will be true in all respects at the time Abicad purchases such shares as if it had been entered into anew at such time and shall not be extinguished by such purchase; (b) such investor shall do all such acts and things as shall be necessary or expedient, and execute any additional documents deemed by Deutsche Bank or Abicad to be desirable, to complete the purchase of the shares referred to in this paragraph; (c) such investor has fully observed any applicable legal requirements, the RABB may be made to him under the laws of all relevant jurisdictions, and the investor's offer to sell shares to Abicad, and any acceptance thereof, shall not be unlawful under the laws of any jurisdiction. Deutsche Bank shall be under no obligation to purchase any shares in the RABB if its arrangements with Abicad terminate.

 

No document soliciting intentions to sell securities has been or will be prepared in connection with any of the transactions described in this announcement. Any investment decision to sell securities as part of the RABB must be made solely on the basis of publicly available information. Such information is not the responsibility of, and has not been independently verified by, Deutsche Bank or Abicad or any of their respective affiliates.

 

Deutsche Bank Aktiengesellschaft is authorised under German Banking Law (competent authority: European Central Bank). It is subject to supervision by the European Central Bank and by BaFin, Germany's Federal Financial Supervisory Authority. Deutsche Bank Aktiengesellschaft is a joint stock corporation incorporated with limited liability in the Federal Republic of Germany, with its head office in Frankfurt am Main where it is registered in the Commercial Register of the District Court under number HRB 30 000.

 

Deutsche Bank is acting exclusively for Abicad and no other person in connection with the RABB. Deutsche Bank will not regard any other person as its client in relation to the RABB and will not be responsible to any other person for providing the protections afforded to its clients, nor for providing advice in relation to the contents of this announcement or any transaction, arrangement or other matter referred to herein (including, without limitation, the RABB).

 

Neither Deutsche Bank nor any of its affiliates nor any of their respective directors, officers, employees, advisers or agents accepts any responsibility or liability whatsoever for, or makes any representation or warranty, express or implied, as to, the truth, accuracy or completeness of the information in this announcement (or whether any information has been omitted from the announcement) or any other information relating to Abicad or Breedon or any of its or their subsidiaries or associated companies, whether written, oral or in a visual or electronic form, and howsoever transmitted or made available or for any loss howsoever arising from any use of this announcement or its contents or otherwise arising in connection therewith.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ROIEAADNEFPDEAA
Date   Source Headline
2nd May 20247:00 amRNSDirector/PDMR Shareholding
30th Apr 20243:06 pmRNSTotal Voting Rights
26th Apr 20243:39 pmRNSDirector/PDMR Shareholding
24th Apr 20244:40 pmRNSResult of AGM
24th Apr 20243:33 pmRNSDirector/PDMR Shareholding
24th Apr 20247:00 amRNSAGM Trading Update
5th Apr 20243:49 pmRNSDirector/PDMR Shareholding
4th Apr 20242:35 pmRNSDirector/PDMR Shareholding
28th Mar 20244:11 pmRNSTotal Voting Rights
18th Mar 202410:00 amRNS2023 Annual Report and Notice of AGM
12th Mar 20243:09 pmRNSApplication for Admission of Consideration Shares
7th Mar 20247:00 amRNSCompletion of Acquisition
6th Mar 20247:00 amRNSAcquisition
6th Mar 20247:00 amRNSFinal Results
29th Feb 20247:00 amRNSTotal Voting Rights
8th Feb 20243:51 pmRNSHolding(s) in Company
5th Feb 202410:00 amRNSNotice of Results
31st Jan 20249:18 amRNSTotal Voting Rights
29th Jan 20244:09 pmRNSHolding(s) in Company
29th Dec 20237:00 amRNSBlock listing six monthly return
29th Dec 20237:00 amRNSTotal Voting Rights
30th Nov 20237:00 amRNSTotal Voting Rights
22nd Nov 20237:00 amRNSNovember Trading Statement
16th Nov 202310:07 amRNSDirector/PDMR Shareholding
8th Nov 20234:01 pmRNSDirector/PDMR Shareholding
31st Oct 20237:00 amRNSTotal Voting Rights
19th Oct 20231:59 pmRNSHolding(s) in Company
9th Oct 20232:24 pmRNSHolding(s) in Company
9th Oct 20232:23 pmRNSDirector/PDMR Shareholding
9th Oct 202311:46 amRNSDirector/PDMR Shareholding
9th Oct 202310:53 amRNSDirector/PDMR Shareholding
9th Oct 202310:47 amRNSHolding(s) in Company
6th Oct 20235:15 pmRNSDirector/PDMR Shareholding
5th Oct 20235:32 pmRNSHolding(s) in Company
3rd Oct 20235:30 pmRNSIntention to acquire additional shares of Breedon
3rd Oct 20237:00 amRNSInvestor site visit
2nd Oct 202311:18 amRNSInterim Dividend Timetable
29th Sep 20239:37 amRNSTotal Voting Rights
31st Aug 202310:15 amRNSTotal Voting Rights
30th Aug 20235:02 pmRNSDirector/PDMR Shareholding
31st Jul 202311:36 amRNSTotal Voting Rights
26th Jul 20237:00 amRNSInterim results 2023
3rd Jul 20231:55 pmRNSNotice of Interim Results 2023
30th Jun 20239:55 amRNSTotal Voting Rights
27th Jun 202311:48 amRNSBlock Listing of Ordinary Shares
13th Jun 202310:51 amRNSReduction of Capital Effective
6th Jun 20235:02 pmRNSOutcome of Court Hearing on Reduction of Capital
2nd Jun 20233:25 pmRNSHolding(s) in Company
1st Jun 202310:37 amRNSHolding(s) in Company
31st May 202312:35 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.